Alkem Laboratories Ltd

Common Name
Alkem Laboratories
Country
India
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
18,785
Ticker
ALKEM
Exchange
NATIONAL STOCK EXCHANGE OF INDIA
Description
Alkem Laboratories Ltd. operates as a prominent pharmaceutical company based in India. The primary function of Alkem Laboratories is the development, manufacture, and distribution of a wide range of p...

Alkem Laboratories's Financial Statements Preview

Below are the financial statements of Alkem Laboratories, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in billions of INR
2025 as of 2025-03-31
2024 as of 2024-03-31
Assets
Non-current assets
Property, plant and equipment
20.64a
21.61a
Right of use assets
3.22a
2.47a
Capital work in progress
4.77a
1.48a
Goodwill
4.23a
4.17a
Other intangible assets
0.43a
0.47a
Intangible assets under development
0.72a
0.1a
Financial assets
Investment in associate
0.32a
0a
Other investments
9.11a
3.35a
Other financial assets
4.75a
1.2a
Deferred tax assets (net)
17.38a
15.15a
Current tax assets (net)
0.65a
0.78a
Other non-current assets
1.23a
0.84a
Total non-current assets
67.45a
51.63a
Current assets
Inventories
29.22a
26.61a
Financial assets
Investments
9.02a
1.49a
Trade receivables
24.66a
22.53a
Cash and cash equivalents
3.04a
4.55a
Bank balances other than (iii) above
12.59a
11.24a
Loans
0.09a
0.09a
Other financial assets
21.15a
29.3a
Other current assets
8.33a
8.3a
Total current assets
108.11a
104.12a
Assets held for sale
1.35a
0a
Total assets
176.91a
155.75a
Equity and liabilities
Equity
Equity share capital
0.24a
0.24a
Other equity
119.61a
102.88a
Equity attributable to owners of the company
119.85a
103.12a
Non-controlling interests
4.49a
4.02a
Total equity
124.34a
107.14a
Liabilities
Non-current liabilities
Financial liabilities
Borrowings
3.11a
0.4a
Lease liabilities
2.67a
1.89a
Other financial liabilities
3.54a
3.11a
Provisions
3.38a
3a
Other non-current liabilities
0.22a
0.26a
Total non-current liabilities
12.92a
8.66a
Current liabilities
Financial liabilities
Borrowings
7.52a
11.74a
Lease liabilities
0.51a
0.15a
Trade payables
Total outstanding dues of micro enterprises and small enterprises
0.88a
0.67a
Total outstanding dues of creditors other than micro and small enterprises
17.51a
16.81a
Other financial liabilities
7.91a
6.46a
Other current liabilities
3.06a
2.3a
Provisions
1.59a
1.27a
Current tax liabilities (net)
0.61a
0.55a
Total current liabilities
39.59a
39.95a
Liabilities classified as held for sale
0.06a
0a
Total liabilities
52.57a
48.61a
Total equity and liabilities
176.91a
155.75a
Download Data

Verified Sources Behind Alkem Laboratories’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Alkem Laboratories’s data sources below and access millions more through our Disclosure Search.

a. Alkem Laboratories's Annual Report 2025
a. Alkem Laboratories's Annual Report 2025
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?